These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 29373149)

  • 21. Non-alcoholic fatty liver disease (Nafld) in obese children- effect of refined carbohydrates in diet.
    Félix DR; Costenaro F; Gottschall CB; Coral GP
    BMC Pediatr; 2016 Nov; 16(1):187. PubMed ID: 27846831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interview with PD Dr. Anton Gillessen, Münster. Non-alcoholic fatty liver: change in the life style!].
    Gillessen A
    MMW Fortschr Med; 2015 Jan; 157(1):69. PubMed ID: 25767868
    [No Abstract]   [Full Text] [Related]  

  • 23. The PNPLA3 p.Ile148Met Variant and Obesity: brothers-in-arms: Comment on: PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
    Krawczyk M; Lammert F
    Surg Obes Relat Dis; 2015; 11(4):894-6. PubMed ID: 25862175
    [No Abstract]   [Full Text] [Related]  

  • 24. High prevalence of nonalcoholic fatty liver disease in the middle east: Lifestyle and dietary habits.
    Eshraghian A
    Hepatology; 2017 Mar; 65(3):1077. PubMed ID: 27859430
    [No Abstract]   [Full Text] [Related]  

  • 25. Association of weight gain since age 20 with non-alcoholic fatty liver disease in normal weight individuals.
    Kimura T; Deshpande GA; Urayama KY; Masuda K; Fukui T; Matsuyama Y
    J Gastroenterol Hepatol; 2015 May; 30(5):909-17. PubMed ID: 25469977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nutrition Interventions for Chronic Liver Diseases and Nonalcoholic Fatty Liver Disease.
    Pimentel CF; Lai M
    Med Clin North Am; 2016 Nov; 100(6):1303-1327. PubMed ID: 27745596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonalcoholic fatty liver disease (NAFLD) pathophysiology in obese children and adolescents: update.
    Assunção SNF; Sorte NCB; Alves CD; Mendes PSA; Alves CRB; Silva LR
    Nutr Hosp; 2017 Jun; 34(3):727-730. PubMed ID: 28627213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obese children with fatty liver: Between reality and disease mongering.
    Ranucci G; Spagnuolo MI; Iorio R
    World J Gastroenterol; 2017 Dec; 23(47):8277-8282. PubMed ID: 29307987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevalence of nonalcoholic fatty liver disease and metabolic abnormalities in 387 obese children and adolescents in Beijing, China].
    Zhou X; Hou DQ; Duan JL; Sun Y; Cheng H; Zhao XY; Liu JT; Yang P; Shan XY; Mi J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 May; 34(5):446-50. PubMed ID: 24016432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonobese Fatty Liver Disease.
    Kim D; Kim WR
    Clin Gastroenterol Hepatol; 2017 Apr; 15(4):474-485. PubMed ID: 27581063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Waist to height ratio: a simple screening tool for nonalcoholic fatty liver disease in obese children.
    Özhan B; Ersoy B; Özkol M; Kiremitci S; Ergin A
    Turk J Pediatr; 2016; 58(5):518-523. PubMed ID: 28621093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nonalcoholic Fatty Liver Disease and Weight Loss].
    Ping F; Li YX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Oct; 40(5):597-602. PubMed ID: 30404689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comment on: utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
    Choi Y
    Surg Obes Relat Dis; 2018 Jan; 14(1):91-92. PubMed ID: 29104002
    [No Abstract]   [Full Text] [Related]  

  • 35. Derivation and validation of a scoring system for predicting nonalcoholic steatohepatitis in Taiwanese patients with severe obesity.
    Tai CM; Yu ML; Tu HP; Huang CK; Hwang JC; Chuang WL
    Surg Obes Relat Dis; 2017 Apr; 13(4):686-692. PubMed ID: 28089433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Treatment with n-3 Polyunsaturated Fatty Acids as a Monotherapy in Children with Nonalcoholic Fatty Liver Disease.
    Boyraz M; Pirgon Ö; Dündar B; Çekmez F; Hatipoğlu N
    J Clin Res Pediatr Endocrinol; 2015 Jun; 7(2):121-7. PubMed ID: 26316434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.
    Clemente MG; Mandato C; Poeta M; Vajro P
    World J Gastroenterol; 2016 Sep; 22(36):8078-93. PubMed ID: 27688650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor 1 and metabolic parameters are associated with nonalcoholic fatty liver disease in obese children and adolescents.
    Liang S; Cheng X; Hu Y; Song R; Li G
    Acta Paediatr; 2017 Feb; 106(2):298-303. PubMed ID: 27889912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index.
    Wang Z; Xu M; Hu Z; Shrestha UK
    Menopause; 2015 Jun; 22(6):667-73. PubMed ID: 25513983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of a noninvasive prediction model for nonalcoholic steatohepatitis resolution after lifestyle intervention.
    Vilar-Gomez E; Yasells-Garcia A; Martinez-Perez Y; Calzadilla-Bertot L; Torres-Gonzalez A; Gra-Oramas B; Gonzalez-Fabian L; Villa-Jimenez O; Friedman SL; Diago M; Romero-Gomez M
    Hepatology; 2016 Jun; 63(6):1875-87. PubMed ID: 26849287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.